S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
Log in

BriaCell Therapeutics Stock Forecast, Price & News

Today's Range N/A
50-Day Range
MA: $5.16
52-Week Range N/A
Volume2,095 shs
Average Volume1,856 shs
Market Capitalization$4.59 million
P/E RatioN/A
Dividend YieldN/A
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing approaches for the management of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Year FoundedN/A



Sales & Book Value

Annual SalesN/A
Book Value($4.55) per share


Net Income$-3,680,000.00


Market Cap$4.59 million
Next Earnings Date3/29/2021 (Estimated)
OptionableNot Optionable


Overall MarketRank

0.00 out of 5 stars

Medical Sector

1922nd out of 1,960 stocks

Pharmaceutical Preparations Industry

761st out of 771 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
30 days | 90 days | 365 days | Advanced Chart

Receive BCTXF News and Ratings via Email

Sign-up to receive the latest news and ratings for BCTXF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

BriaCell Therapeutics (OTCMKTS:BCTXF) Frequently Asked Questions

What stocks does MarketBeat like better than BriaCell Therapeutics?

Wall Street analysts have given BriaCell Therapeutics a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but BriaCell Therapeutics wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting BriaCell Therapeutics?

BriaCell Therapeutics saw a decrease in short interest in January. As of January 29th, there was short interest totaling 200 shares, a decrease of 33.3% from the January 14th total of 300 shares. Based on an average daily trading volume, of 700 shares, the days-to-cover ratio is currently 0.3 days.
View BriaCell Therapeutics' Short Interest

When is BriaCell Therapeutics' next earnings date?

BriaCell Therapeutics is scheduled to release its next quarterly earnings announcement on Monday, March 29th 2021.
View our earnings forecast for BriaCell Therapeutics

How were BriaCell Therapeutics' earnings last quarter?

BriaCell Therapeutics Corp. (OTCMKTS:BCTXF) announced its quarterly earnings results on Monday, November, 30th. The company reported ($0.58) earnings per share (EPS) for the quarter.
View BriaCell Therapeutics' earnings history

Who are BriaCell Therapeutics' key executives?

BriaCell Therapeutics' management team includes the following people:
  • Dr. William V. Williams M.D., CEO, Pres & Director
  • Dr. Charles Louis Wiseman M.D., FACP, Founder & Director
  • Mr. Gadi Levin B.Com., C.A., M.B.A., CPA, MBA, CFO & Corp. Sec. (Age 48)
  • Ms. Farrah Dean, Mang. of Corp. Devel.

Who are some of BriaCell Therapeutics' key competitors?

What is BriaCell Therapeutics' stock symbol?

BriaCell Therapeutics trades on the OTCMKTS under the ticker symbol "BCTXF."

How do I buy shares of BriaCell Therapeutics?

Shares of BCTXF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

How much money does BriaCell Therapeutics make?

BriaCell Therapeutics has a market capitalization of $0.00.

How many employees does BriaCell Therapeutics have?

BriaCell Therapeutics employs 5 workers across the globe.

What is BriaCell Therapeutics' official website?

The official website for BriaCell Therapeutics is www.briacell.com.

Where are BriaCell Therapeutics' headquarters?

BriaCell Therapeutics is headquartered at 3RD FLOOR BELLEVUE CENTRE 235-15TH STR, WEST VANCOUVER A1, V7T 2X1.

How can I contact BriaCell Therapeutics?

BriaCell Therapeutics' mailing address is 3RD FLOOR BELLEVUE CENTRE 235-15TH STR, WEST VANCOUVER A1, V7T 2X1. The company can be reached via phone at 604-921-1810.

This page was last updated on 2/27/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.